Brain Metastases News and Research

RSS
Preclinical study strongly supports NT-113 as potential new treatment for glioblastoma multiforme

Preclinical study strongly supports NT-113 as potential new treatment for glioblastoma multiforme

CCR5 receptor plays key role in driving prostate cancer metastases

CCR5 receptor plays key role in driving prostate cancer metastases

Research shows that immune checkpoint inhibitors may work in glioblastoma, brain metastases

Research shows that immune checkpoint inhibitors may work in glioblastoma, brain metastases

Adjuvant cisplatin for NSCLC raises non-cancer mortality risk

Adjuvant cisplatin for NSCLC raises non-cancer mortality risk

Afatinib active against NSCLC nervous system metastases

Afatinib active against NSCLC nervous system metastases

VAL-083 drug compound shows promise against non-small cell lung cancer

VAL-083 drug compound shows promise against non-small cell lung cancer

AZD9291 shows median progression-free survival in patients with EGFRm T790M+ advanced NSCLC

AZD9291 shows median progression-free survival in patients with EGFRm T790M+ advanced NSCLC

Trastuzumab offers better outcome than lapatinib for HER2-positive breast cancer patients

Trastuzumab offers better outcome than lapatinib for HER2-positive breast cancer patients

Alectinib promise for crizotinib-resistant NSCLC

Alectinib promise for crizotinib-resistant NSCLC

AANS, ASTRO partner to launch national registry for SRS treatments

AANS, ASTRO partner to launch national registry for SRS treatments

Stereotactic radiosurgery feasible for multiple brain metastases

Stereotactic radiosurgery feasible for multiple brain metastases

CCC study provides hope that SapC-DOPS could be used for metastatic brain cancer treatment

CCC study provides hope that SapC-DOPS could be used for metastatic brain cancer treatment

Lung cancer and melanoma funders form first-ever research collaboration

Lung cancer and melanoma funders form first-ever research collaboration

Elderly mRCC patients should not be excluded from targeted therapy option

Elderly mRCC patients should not be excluded from targeted therapy option

Key historical misconceptions hinder research and treatment for brain metastases

Key historical misconceptions hinder research and treatment for brain metastases

Angiochem presents data on ANG1005 paclitaxel-peptide drug conjugate at 50th ASCO annual meeting

Angiochem presents data on ANG1005 paclitaxel-peptide drug conjugate at 50th ASCO annual meeting

FDA grants Angiochem’s ANG1005 fast track and orphan drug designation for treatment of glioblastoma multiforme

FDA grants Angiochem’s ANG1005 fast track and orphan drug designation for treatment of glioblastoma multiforme

Angiochem commences ANG1005 Phase 2 clinical study in HER2+ breast cancer patients with brain metastases

Angiochem commences ANG1005 Phase 2 clinical study in HER2+ breast cancer patients with brain metastases

IMPAKT breast cancer conference abstracts online

IMPAKT breast cancer conference abstracts online

Study demonstrates efficacy, tolerability of vemurafenib in aggressive form of metastatic melanoma

Study demonstrates efficacy, tolerability of vemurafenib in aggressive form of metastatic melanoma

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.